| Product Name | MF | CAS | Details |
|---|
| Azt-pmap | C20H25N6O8P | 142629-81-0 | Details |
| Mesulergine hydrochloride | C18H27ClN4O2S | 72786-12-0 | Details |
| Rhodamine 123 free base | C21H17N2O3+ | 104114-27-4 | Details |
| MK-8318 | C27H26F4N2O5 | 1416581-40-2 | Details |
| UbcH5c-IN-1 | C22H21BrO3 | 2123480-72-6 | Details |
| BMS-248360 | C36H45N5O5S | 254737-87-6 | Details |
| ZEN-3862 | C19H17FN2O3 | 1952264-33-3 | Details |
| SRT3657 | C40H54N8O6S | 1383551-17-4 | Details |
| 8-CSC | C16H15ClN4O2 | 148589-13-3 | Details |
| Retosiban | C27H34N4O5 | 820957-38-8 | Details |
| ML-9 Free Base | C15H17ClN2O2S | 110448-31-2 | Details |
| Autotaxin-IN-1 | C21H23N7O2 | 1619971-30-0 | Details |
| Daporinad hydrochloride | C24H30ClN3O2 | 1785666-54-7 | Details |
| TXNIP-IN-1 | C12H12N2O4 | 1268955-50-5 | Details |
| β-glycosidase-IN-1 | C13H23NO5 | 176485-27-1 | Details |
| GNE-0946 | C22H12ClF3N2O4 | 1677667-24-1 | Details |
| PS315 | C23H19ClO2 | 1221964-50-6 | Details |
| (S)-PF-03716556 | C22H26N4O3 | 928774-44-1 | Details |
| Ascamycin | 91432-48-3 | Details |
| Amitifadine free base | C11H11Cl2N | 410074-73-6 | Details |
| MK-0674 | C26H27F6N3O2 | 887781-62-6 | Details |
| MR 16728 hydrochloride | C23H37ClN2O | 207403-36-9 | Details |
| Crizotinib acetate | C23H26Cl2FN5O3 | 877399-53-6 | Details |
| Syncytial Virus Inhibitor-1 | C23H26N4O3S | 1422496-79-4 | Details |
| Telomerase-IN-3 | C19H16ClN5O3 | 150096-77-8 | Details |
| TL02-59 dihydrochloride | C32H35ClF3N5O4 | 2415263-06-6 | Details |
| PKF050-638 | C13H13ClN4O2 | 528893-52-9 | Details |
| Zindoxifene | C21H21NO4 | 86111-26-4 | Details |
| (S)-Purvalanol B | C20H25ClN6O3 | 2310135-61-4 | Details |
| PSB-1114 tetrasodium | C10H16F2N2NaO13P3S | 1657025-60-9 | Details |
| AZD0424 | C25H29ClN6O5 | 692054-06-1 | Details |
| Top1 inhibitor 1 | C24H22N6O2 | 2302772-05-8 | Details |
| TSHR antagonist S37a | C25H20N2O3S2 | 2143452-20-2 | Details |
| TAB29 | C28H22O3 | 2361144-71-8 | Details |
| USP7-IN-6 | C41H43N7O4S | 2166586-47-4 | Details |
| PCS1055 dihydrochloride | C27H33ClN4 | 361979-40-0 | Details |
| SB-267268 | C22H24F3N3O4 | 205678-26-8 | Details |
| Levofloxacin sodium | C18H21FN3NaO4 | 872606-49-0 | Details |
| Aganodine | C9H10Cl2N4 | 86696-87-9 | Details |
| Seletracetam | C10H14F2N2O2 | 357336-74-4 | Details |
| MRS2500 tetraammonium | C13H21IN6O8P2 | 630103-23-0 | Details |
| PSB 11 hydrochloride | C16H18ClN5O | 453591-58-7 | Details |
| Diarylalkane derivative 1 | C34H51NO4 | 191155-65-4 | Details |
| Mcl1-IN-3 | C27H22ClN3O4 | 1814891-79-6 | Details |
| BI-1950 | C32H26Cl2FN7O3 | 1159724-42-1 | Details |
| ZEN-3411 | C21H20N4O2 | 1952264-36-6 | Details |
| SMYD2-IN-1 | C25H25Cl2F2N7O2 | 2023788-96-5 | Details |
| SSTR5 antagonist 1 | C28H34FN3O5 | 1628741-91-2 | Details |
| TD-0212 TFA | C30H35F4N3O6S | 1073549-11-7 | Details |
| FN-1501-propionic acid | C25H27N9O4 | 2408642-48-6 | Details |
| Synucleozid hydrochloride | C22H21ClN6 | 2741856-68-6 | Details |
| TAS05567 | C21H29N9O2 | 1429038-15-2 | Details |
| AN7973 | C19H17BClN3O3 | 1620899-32-2 | Details |
| AP5 | C28H28FNO4 | 1623194-37-5 | Details |
| TRPA1 Antagonist 1 | C24H23F6N5NaO7PS | 1984825-08-2 | Details |
| TGFBR1-IN-1 | C23H17N5O2S | 2170830-26-7 | Details |
| O-2050 | C23H31NO4S | 1883545-42-3 | Details |
| 5-TAMRA chloride(91809-66-4 free base) | C25H23ClN2O5 | 125481-77-8 | Details |
| Xanthine amine congener trihydrochloride | C21H29ClN6O4 | 2459963-12-1 | Details |
| Vandetanib Fumarate | C22H24BrFN4O2 | 338992-00-0 | Details |
| WAY 629 hydrochloride | C15H19ClN2 | 57756-44-2 | Details |
| BMT-090605 | C21H24N4O2 | 1551403-51-0 | Details |
| Hsp90-Cdc37-IN-1 | C43H57FN2O6S | 2227303-22-0 | Details |
| CDK8-IN-3 | C22H23N5O2 | 1884500-15-5 | Details |
| JNJ-46281222 | C23H25F3N4 | 1254980-38-5 | Details |
| Codon readthrough inducer 1 | C15H11N3O5 | 1338233-09-2 | Details |
| SDM25N hydrochloride | C26H27ClN2O3 | 342884-71-3 | Details |
| TAK-828F | C28H32FN3O5 | 1854901-94-2 | Details |
| LP-922761 | C21H26N6O3 | 1454808-95-7 | Details |
| ZEN-3219 | C19H18N2O3 | 1952264-34-4 | Details |
| VU6005806 | C17H16F3N7O2S | 2180914-37-6 | Details |
| 3M-011 | C18H25N5O3S | 642473-62-9 | Details |
| RX 67668 | C16H24ClN | 40709-76-0 | Details |
| Hypoglycemic agent 1 | C25H24FN5O4 | 2253733-57-0 | Details |
| Gemcitabine elaidate hydrochloride | C27H43F2N3O5.ClH | 2918768-08-6 | Details |
| MK-0493 | C30H38ClF2N3O2 | 455956-93-1 | Details |
| XL-784 free base | C21H22ClF2N3O8S | 1356992-21-6 | Details |
| TA-316 | C28H25BrN4O5S2 | 1429321-13-0 | Details |
| TP-008 | C20H15ClFN5O2 | 1976038-41-1 | Details |
| Taribavirin | C8H13N5O4 | 119567-79-2 | Details |
| Sitravatinib malate | C37H35F2N5O9S | 2244864-88-6 | Details |
| TDP1 Inhibitor-1 | C26H26N2O5 | 2248702-80-7 | Details |
| Wnt pathway activator 2 | C17H15NO4 | 1360540-82-4 | Details |
| LY88074 analog 1 | C25H21NO5S | 183060-99-3 | Details |
| BRD9185 | C23H21F6N3O2 | 2057420-29-6 | Details |
| Neurodegenerative Disorder-Targeting Compound 1 | C28H28N4O4 | 1254698-39-9 | Details |
| Cys modifier 1 | C18H15N5O5 | 2374314-08-4 | Details |
| Leuphasyl TFA | C31H40F3N5O9 | 67586-27-0 | Details |
| Notch inhibitor 1 | C26H25F7N4O3 | 1584647-27-7 | Details |
| CI 972 anhydrous | C11H12ClN5OS | 115787-68-3 | Details |
| MAK683-CH2CH2COOH | C23H21FN6O3 | 2639882-68-9 | Details |
| Irbesartan HCl | C25H29ClN6O | 329055-23-4 | Details |
| CCG258208 | C24H25FN4O4 | 2055990-90-2 | Details |
| Asenapine hydrochloride | C17H17Cl2NO | 1261398-77-9 | Details |
| VU041 | C19H20F3N3O | 332943-64-3 | Details |
| 5-Et-ddU | C11H16N2O4 | 108895-49-4 | Details |
| (S)-BI-1001 | C19H15BrClNO3 | 957889-73-5 | Details |
| VHL Ligand 8 | C23H29N3O6 | 2701565-76-4 | Details |
| AMG-1694 | C23H30F3N3O4S2 | 1361217-07-3 | Details |
| Afurolol | C15H21NO4 | 65776-67-2 | Details |
| Product Total： Product Page： | ||||
| 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 | ||||